Martin Gebel
Bayer (Germany)(DE)
Publications by Year
Research Areas
Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes, Hormonal Regulation and Hypertension, Blood Pressure and Hypertension Studies, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis(2021)1,080 cited
- → Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study(2015)244 cited
- → Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use(2015)207 cited
- → Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis(2022)181 cited
- → A sonographically guided technique for central venous access.(1997)148 cited
- → Bleeding Risk of Patients With Acute Venous Thromboembolism Taking Nonsteroidal Anti-Inflammatory Drugs or Aspirin(2014)141 cited
- → Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism(2021)133 cited
- → Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone(2020)113 cited
- → A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease(2022)91 cited
- → Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis(2021)48 cited